Glaucoma is the second-leading cause of blindness worldwide, and is currently incurable.

The strategic collaboration between ZEISS Medical Technology and Envision Health Technologies combines ZEISS’ long-term innovation strategy and leadership in visual field testing with Envision’s ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Black and multiracial children had significantly lower ...

Please provide your email address to receive an email when new articles are posted on . Angling a patient’s face can negate the effect of facial contour on visual field testing. AI may help predict ...

The COVID-19 pandemic made it clear that we need novel solutions for monitoring patients with chronic diseases such as glaucoma. One area that is particularly ripe for disruption is perimetry testing.

Same-visit visual field test and optic nerve head imaging — even with 3D OCT neuroretinal rim minimum distance band thickness — may show different rates of disease progression, suggesting a need for ...

We aimed to develop a model to predict visual field (VF) in the central 10 degrees in patients with glaucoma, by training a convolutional neural network (CNN) with optical coherence tomography (OCT) ...

Glaucoma is often called the "silent thief of sight" because it can gradually damage vision for years before noticeable ...

Glaucoma often develops with no warning signs, no pain, and no noticeable symptoms until permanent vision loss has already ...